An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in a laboratory, can aid in treating teeth in patients with head and neck cancer. In these cases, radiotherapy very close to the mouth can destroy salivary glands and compromise saliva production, which is essential for controlling bacteria and disease.
A McGill University research team has developed a painless, automated way to deliver in vitro fertilization (IVF) hormones using a light-activated microneedle patch, an innovation that could ease one of the most stressful parts of fertility treatment and open new possibilities for other diseases that require frequent, time-sensitive injections.
In earlier work, a team led by researchers at the Broad Institute and Mass General Brigham discovered a key cell type underlying fibrosis in inflammatory bowel disease (IBD). Now, in a new study published in Nature, the team has characterized the crosstalk between this and other types of cells that leads to fibrosis.
Past research has found that exposure to bright lights and high levels of noise can alter both physiological processes and human behavior. For instance, an elevated or limited exposure to bright lights and noise has been found to influence people’s sleeping patterns, circadian rhythm, mood, metabolism, stress levels and mental performance.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Nanomaterial crosses blood-brain barrier, targets harmful inflammation after most common type of stroke
CINCINNATI, Jan. 6, 2026 /PRNewswire/ — LiverRight, the nation’s only National Virtual Clinic for diagnosing and treating Liver Disease in Adults, announces that its telemedicine appointments in 2026 will offer metrics collection using what’s called Contactless Remote Patient Monitoring (RPM).
The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.
Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced today that it plans to launch a new, FDA-cleared artificial heart accessory.
A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered striking molecular connections between schizophrenia and bone health, identifying 195 shared genetic loci that may explain why psychiatric patients face elevated fracture risks.